The bizarre phenomenon of the pharmaceutical industry with its 93 price earning ratio without any bubble controversy
The average price earning ratio(PER) of the pharmaceutical industry is observed to be 93.4. PER, a ratio of a company’s current share price compared to its per-share earnings, indicates a number of times for a share price over per-share earnings.
Considering the average PER of listed pharmaceuti...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
